New Report Examines Healthcare Analytical Testing Services Market In The World

1. MarketsandMarkets Presents Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 https://www.marketsandmarkets.com/Market-Reports/healthcare-analytical-testing-services-market-108923833.html

2. The report "Healthcare Analytical Testing Services Marketby Type (Method Development & Validation, Cell-based Assays, Stability Testing, Heavy Metal Testing, Thermal Analysis, Cleaning Validation), End User (Pharmaceutical Companies, CROs) - Global Forecast to 2026" The healthcare analytical testing services market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%. Growth in the market is driven by analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, and rising number of clinical trials. In this report the global healthcare analytical testing services market is segmented by type, end user, and region. The healthcare analytical testing services market exhibited a dip in the year-on-year growth rate for the first half of 2020 since the COVID-19 outbreak resulted in decreased drug production in many countries. This impacted many segments of the analytical testing market, such as raw material testing and physical characterization services. However, there has been a solid recovery in the market from Q3 2020, fueled by growth in the pharmaceutical industry in response to the COVID-19 pandemic. In this report, the global healthcare analytical testing services market is segmented by type, end user, and region. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownload

3. Objectives of the Study: • To define, describe, analyze, and forecast the size of the healthcare analytical testing services market on the basis of type, end-user, and region. • To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) • To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market • To forecast the size of the market segments with respect to North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. • To profile key players and comprehensively analyze their service portfolios, market positions, and core competencies. • To track and analyze competitive developments such as service launches, expansions, partnerships, agreements, collaborations, acquisitions and other developments in the market. • To benchmark players within the healthcare analytical testing services market using the Competitive Leadership Mapping framework which analyzes market players on various parameters within the broad categories of business and service strategy. • Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst

4. The research report categorizes the market into the following segments and subsegments: By Type Bioanalytical Testing Services Physical Characterization Services Method Development & Validation Testing Services Raw Material Testing Services Batch-Release Testing Services Stability Testing Microbial Testing Services Environmental Monitoring Services By End User Pharmaceutical & Biopharmaceutical Companies Medical Device Companies Clinical Research Organizations

5. Prominent players in the healthcare analytical testing services market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXiAppTec Co. Ltd. (China), PPD, Inc. (US), Element Materials Technology (UK), Thermo Fisher Scientific (US), Pace Analytical Services, LLC. (US), Intertek Group LLC. (UK), Merck KGaA (Germany), Danaher Corporation (US), Source BioScience (UK), Almac Group (UK), ICON plc (Ireland), Frontage Laboratories, Inc. (US), STERIS plc (US), Sartorius AG (Germany), ALS Life Science (US), Syneos Health (US), Medpace Holdings, Inc. (US), Cinven (LGC Limited) (UK), Anacura (Belgium), Impact Analytical (US), & CD BioSciences (US).

6. Company Insights Eurofins Scientific (US) is a leading player in the healthcare analytical testing services market and accounted for the largest share of the market in 2020. The company’s services in the healthcare analytical testing services market quality control, manufacturing/process validation, analytical development, microbiology, and other testing for pharmaceutical and biopharmaceutical industries. In August 2021, Eurofins Scientific acquired a CRO, bioskin GmbH (Germany), to strengthen Eurofins’ leadership position. Similarly, in November 2020, the company acquired Taiyo Techno Research (Japan) to strengthen its market leadership in Japan. LabCorp (US) is one of the prominent players in the healthcare analytical testing services market. The company operates through two key segments—LabCorp Diagnostics (Dx) and LabCorp Drug Development (DD). Dx is an independent clinical laboratory business, while the DD segment provides end-to-end drug development and medical device & companion diagnostic development solutions from early-stage research to clinical development and commercial market access. The company provides healthcare analytical testing service offerings through its LabCorp Drug Development operating segment. In June 2019, LabCorp’s Covance Drug Development business completed the acquisition of Envigo, a leading provider of research models and services to enhance research support for biopharmaceutical & life sciences industries.

7. About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

8. Contact Us Contact:Mr. Aashish MehraMarketsandMarkets™ INC. 630 Dundee Road, Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 sales@marketsandmarkets.com Press release: https://www.marketsandmarkets.com/PressReleases/healthcare-analytical-testing-services.asp Research insights: https://www.marketsandmarkets.com/ResearchInsight/healthcare-analytical-testing-services-market.asp